Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease
暂无分享,去创建一个
David A Bennett | Julie A Schneider | Aron S Buchman | S. Leurgans | V. Vanderhorst | J. Shulman | A. Buchman | S. Nag | A. Lim | David A. Bennett | Sue E Leurgans | Joshua M Shulman | Sukriti Nag | Andrew S P Lim | Veronique G J M VanderHorst | J. Schneider | J. Schneider | Veronique G Vanderhorst
[1] Chris Zarow,et al. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. , 2003, Archives of neurology.
[2] K. Rommelfanger,et al. Norepinephrine: The redheaded stepchild of Parkinson's disease. , 2007, Biochemical pharmacology.
[3] K. Deisseroth,et al. Tuning arousal with optogenetic modulation of locus coeruleus neurons , 2010, Nature Neuroscience.
[4] P. Cavallari,et al. Human Neuroscience Hypothesis and Theory Article a Role for Locus Coeruleus in Parkinson Tremor , 2022 .
[5] S. Leurgans,et al. Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study , 2011, BMC Medicine.
[6] D. Dickson,et al. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease , 2008, Acta Neuropathologica.
[7] E. Louis,et al. Mild Parkinsonian signs: An overview of an emerging concept , 2007, Movement disorders : official journal of the Movement Disorder Society.
[8] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[9] C. Finley,et al. Structure of the Human Brain , 1976 .
[10] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[11] A. Bonnet,et al. Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. , 2006, Archives of neurology.
[12] D. Bennett,et al. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[13] D. Dickson,et al. Incidental Lewy body disease and preclinical Parkinson disease. , 2008, Archives of neurology.
[14] Thomas Gasser,et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.
[15] K. Jellinger,et al. Critical evaluation of the Braak staging scheme for Parkinson's disease , 2010, Annals of neurology.
[16] Clifford B Saper,et al. Spinal projections of the A5, A6 (locus coeruleus), and A7 noradrenergic cell groups in rats , 2012, The Journal of comparative neurology.
[17] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[18] N. Schupf,et al. Mild parkinsonian signs are associated with increased risk of dementia in a prospective, population‐based study of elders , 2010, Movement disorders : official journal of the Movement Disorder Society.
[19] B. Yan,et al. Association between mild parkinsonian signs and mortality in an elderly male cohort in China , 2010, Journal of Clinical Neuroscience.
[20] S. Leurgans,et al. Nigral pathology and parkinsonian signs in elders without Parkinson disease , 2012, Annals of neurology.
[21] J. Schneider,et al. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study , 2006, The Lancet Neurology.
[22] News Report , 1969 .
[23] C. Tanner,et al. Parkinsonian signs and substantia nigra neuron density in decendents elders without PD , 2004, Annals of neurology.
[24] D. Maraganore,et al. Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. , 2009, Archives of neurology.
[25] J. Schneider,et al. Overview and findings from the rush Memory and Aging Project. , 2012, Current Alzheimer research.
[26] Stephen J. DeArmond,et al. Structure of the human brain : a photographic atlas , 1974 .